On May 18, 2022, the board of directors of the Biofrontera Inc. appointed Kevin D. Weber to the Nominating and Corporate Governance, Audit and Compensation committees of the board of directors, effective as of May 18, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | +1.81% | +1.20% | -38.99% |
Mar. 18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.99% | 8.6M | |
+25.87% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.89% | 233B | |
+5.33% | 201B | |
-10.06% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- BFRI Stock
- News Biofrontera Inc.
- Biofrontera Inc. Appoints Kevin D. Weber to the Nominating and Corporate Governance, Audit and Compensation Committees